21 March 2022
Mind Your Business: Sylvan Group puts US$140.5m in four local healthcare and pharmaceutical companies
Sylvan Group recently made headlines after announcing that it is investing US$140.5 million to take majority stakes in four healthcare and pharmaceutical companies in Singapore. Kyungsun Chung, Co-Founder & Managing Partner, The Sylvan Group shares why the group has a particular core focus on impact investing and what goes behind the selection process in his company when choosing a company to invest in.

Download the podcast.